Please enable JavaScript to continue using this application.

Compare $ANVS vs $CRBU | Chartloom

Compare

$ANVS vs $CRBU

Annovis Bio Inc · Caribou Biosciences Inc

ANVS

Annovis Bio Inc

CRBU

Caribou Biosciences Inc

Compare $ANVS vs $CRBU

Comparing Annovis Bio Inc and Caribou Biosciences Inc

ANVSAnnovis Bio Inc

CRBUCaribou Biosciences Inc

ANVSAnnovis Bio Inc

Market cap

$42M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-66.8%

52W performance

-46.7%

FCF yield

-103.4%

CRBUCaribou Biosciences Inc

Market cap

$46M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

10.0%

YTD performance

-71.1%

52W performance

-82.8%

FCF yield

-210.7%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ANVS

CRBU

Detailed metrics comparison

ANVS

Annovis Bio Inc

CRBU

Caribou Biosciences Inc

Market Cap

ANVS$42M

CRBU$46M

Enterprise Value

ANVS$23M

CRBU$19M

Price

ANVS$1.21

CRBU$0.46

P/E Ratio

ANVSN/A

CRBUN/A

P/S Ratio

ANVS0.00x

CRBU4.55x

EV/Sales

ANVS0.00x

CRBU1.94x

EV/EBITDA

ANVS0.00x

CRBU0.00x

P/B Ratio

ANVS16.11x

CRBU1.33x

P/FCF Ratio

ANVSN/A

CRBUN/A

EV/FCF

ANVS-0.54x

CRBU-0.20x

PEG Ratio

ANVSN/A

CRBUN/A

Forward P/E (NTM)

ANVSN/A

CRBUN/A

Forward P/S (NTM)

ANVSN/A

CRBUN/A

Revenue (TTM)

ANVS$0

CRBU$10M

Revenue Growth (YoY)

ANVSN/A

CRBU10.0%

Forward Rev Growth

ANVS507.4%

CRBU15.8%

Gross Margin (TTM)

ANVS0.0%

CRBU0.0%

Operating Margin (TTM)

ANVS0.0%

CRBU0.0%

EBITDA Margin (TTM)

ANVS0.0%

CRBU-1065.1%

Net Margin (TTM)

ANVS0.0%

CRBU-1030.4%

FCF Margin (TTM)

ANVSN/A

CRBU-958.5%

Net Income (TTM)

ANVS$-50M

CRBU$-103M

FCF (TTM)

ANVS$-43M

CRBU$-96M

EPS (TTM)

ANVS-$1.32

CRBU-$1.02

ROE (TTM)

ANVS-31808.0%

CRBU-8911.0%

ROA (TTM)

ANVS-25878.0%

CRBU-6247.0%

ROIC (TTM)

ANVS-31808.0%

CRBU-8911.0%

Cash

ANVS$19M

CRBU$26M

Debt

ANVS$0

CRBU$0

Net Cash/Debt

ANVS$19M

CRBU$26M

Current Ratio (TTM)

ANVS3.47x

CRBU6.49x

Quick Ratio (TTM)

ANVS2.95x

CRBU6.36x

Debt/Equity (TTM)

ANVS0.00x

CRBU0.00x

Debt/Assets (TTM)

ANVS0.0%

CRBU0.0%

Interest Coverage (TTM)

ANVSN/A

CRBUN/A

Net Debt/EBITDA (TTM)

ANVS0.00x

CRBU0.00x

Beta

ANVS1.32

CRBU2.46

52W Performance

ANVS-46.7%

CRBU-82.8%

YTD Performance

ANVS-66.8%

CRBU-71.1%

% from 52W High

ANVS-78.0%

CRBU-87.0%

% from 52W Low

ANVS16.3%

CRBU4.0%

Asset Turnover (TTM)

ANVS0.00x

CRBU0.06x

FCF Yield (TTM)

ANVS-103.4%

CRBU-210.7%

Earnings Yield (TTM)

ANVS-118.1%

CRBU-226.5%

Dividend Yield (TTM)

ANVSN/A

CRBUN/A

Rule of 40

ANVS0.0

CRBU-948.5

EV/GP/RG

ANVSN/A

CRBUN/A

Ticker research

View ANVS research View CRBU research

Metric	ANVS Annovis Bio Inc	CRBU Caribou Biosciences Inc
Market & Valuation
Market Cap	$42M	$46M
Enterprise Value	$23M	$19M
Price	$1.21	$0.46
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	4.55x
EV/Sales	0.00x	1.94x
EV/EBITDA	0.00x	0.00x
P/B Ratio	16.11x	1.33x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.54x	-0.20x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$10M
Revenue Growth (YoY)	N/A	10.0%
Forward Rev Growth	507.4%	15.8%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-1065.1%
Net Margin (TTM)	0.0%	-1030.4%
FCF Margin (TTM)	N/A	-958.5%
Net Income (TTM)	$-50M	$-103M
FCF (TTM)	$-43M	$-96M
EPS (TTM)	-$1.32	-$1.02
ROE (TTM)	-31808.0%	-8911.0%
ROA (TTM)	-25878.0%	-6247.0%
ROIC (TTM)	-31808.0%	-8911.0%
Financial Health
Cash	$19M	$26M
Debt	$0	$0
Net Cash/Debt	$19M	$26M
Current Ratio (TTM)	3.47x	6.49x
Quick Ratio (TTM)	2.95x	6.36x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.32	2.46
52W Performance	-46.7%	-82.8%
YTD Performance	-66.8%	-71.1%
% from 52W High	-78.0%	-87.0%
% from 52W Low	16.3%	4.0%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.06x
FCF Yield (TTM)	-103.4%	-210.7%
Earnings Yield (TTM)	-118.1%	-226.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-948.5
EV/GP/RG	N/A	N/A
Ticker research	View ANVS research	View CRBU research

Valuation

P/S Ratio

ANVS

0.00x

CRBU

4.55x

EV/FCF

ANVS

-0.54x

CRBU

-0.20x

Growth & revenue

Revenue Growth TTM

CRBU

10.0%

Forward Revenue Growth

ANVS

507.4%

CRBU

15.8%

Profitability & performance

Gross Margin

ANVS

0.0%

CRBU

0.0%

ROE

CRBU

-8911.0%

ANVS

-31808.0%

FCF Yield %

ANVS

-103.4%

CRBU

-210.7%

52-Week Performance

ANVS

-46.7%

CRBU

-82.8%

Detailed metrics comparison

ANVS

Annovis Bio Inc

CRBU

Caribou Biosciences Inc

Market Cap

ANVS$42M

CRBU$46M

Enterprise Value

ANVS$23M

CRBU$19M

Price

ANVS$1.21

CRBU$0.46

P/E Ratio

ANVSN/A

CRBUN/A

P/S Ratio

ANVS0.00x

CRBU4.55x

EV/Sales

ANVS0.00x

CRBU1.94x

EV/EBITDA

ANVS0.00x

CRBU0.00x

P/B Ratio

ANVS16.11x

CRBU1.33x

P/FCF Ratio

ANVSN/A

CRBUN/A

EV/FCF

ANVS-0.54x

CRBU-0.20x

PEG Ratio

ANVSN/A

CRBUN/A

Forward P/E (NTM)

ANVSN/A

CRBUN/A

Forward P/S (NTM)

ANVSN/A

CRBUN/A

Revenue (TTM)

ANVS$0

CRBU$10M

Revenue Growth (YoY)

ANVSN/A

CRBU10.0%

Forward Rev Growth

ANVS507.4%

CRBU15.8%

Gross Margin (TTM)

ANVS0.0%

CRBU0.0%

Operating Margin (TTM)

ANVS0.0%

CRBU0.0%

EBITDA Margin (TTM)

ANVS0.0%

CRBU-1065.1%

Net Margin (TTM)

ANVS0.0%

CRBU-1030.4%

FCF Margin (TTM)

ANVSN/A

CRBU-958.5%

Net Income (TTM)

ANVS$-50M

CRBU$-103M

FCF (TTM)

ANVS$-43M

CRBU$-96M

EPS (TTM)

ANVS-$1.32

CRBU-$1.02

ROE (TTM)

ANVS-31808.0%

CRBU-8911.0%

ROA (TTM)

ANVS-25878.0%

CRBU-6247.0%

ROIC (TTM)

ANVS-31808.0%

CRBU-8911.0%

Cash

ANVS$19M

CRBU$26M

Debt

ANVS$0

CRBU$0

Net Cash/Debt

ANVS$19M

CRBU$26M

Current Ratio (TTM)

ANVS3.47x

CRBU6.49x

Quick Ratio (TTM)

ANVS2.95x

CRBU6.36x

Debt/Equity (TTM)

ANVS0.00x

CRBU0.00x

Debt/Assets (TTM)

ANVS0.0%

CRBU0.0%

Interest Coverage (TTM)

ANVSN/A

CRBUN/A

Net Debt/EBITDA (TTM)

ANVS0.00x

CRBU0.00x

Beta

ANVS1.32

CRBU2.46

52W Performance

ANVS-46.7%

CRBU-82.8%

YTD Performance

ANVS-66.8%

CRBU-71.1%

% from 52W High

ANVS-78.0%

CRBU-87.0%

% from 52W Low

ANVS16.3%

CRBU4.0%

Asset Turnover (TTM)

ANVS0.00x

CRBU0.06x

FCF Yield (TTM)

ANVS-103.4%

CRBU-210.7%

Earnings Yield (TTM)

ANVS-118.1%

CRBU-226.5%

Dividend Yield (TTM)

ANVSN/A

CRBUN/A

Rule of 40

ANVS0.0

CRBU-948.5

EV/GP/RG

ANVSN/A

CRBUN/A

Ticker research

View ANVS research View CRBU research

Metric	ANVS Annovis Bio Inc	CRBU Caribou Biosciences Inc
Market & Valuation
Market Cap	$42M	$46M
Enterprise Value	$23M	$19M
Price	$1.21	$0.46
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	4.55x
EV/Sales	0.00x	1.94x
EV/EBITDA	0.00x	0.00x
P/B Ratio	16.11x	1.33x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.54x	-0.20x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$10M
Revenue Growth (YoY)	N/A	10.0%
Forward Rev Growth	507.4%	15.8%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-1065.1%
Net Margin (TTM)	0.0%	-1030.4%
FCF Margin (TTM)	N/A	-958.5%
Net Income (TTM)	$-50M	$-103M
FCF (TTM)	$-43M	$-96M
EPS (TTM)	-$1.32	-$1.02
ROE (TTM)	-31808.0%	-8911.0%
ROA (TTM)	-25878.0%	-6247.0%
ROIC (TTM)	-31808.0%	-8911.0%
Financial Health
Cash	$19M	$26M
Debt	$0	$0
Net Cash/Debt	$19M	$26M
Current Ratio (TTM)	3.47x	6.49x
Quick Ratio (TTM)	2.95x	6.36x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.32	2.46
52W Performance	-46.7%	-82.8%
YTD Performance	-66.8%	-71.1%
% from 52W High	-78.0%	-87.0%
% from 52W Low	16.3%	4.0%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.06x
FCF Yield (TTM)	-103.4%	-210.7%
Earnings Yield (TTM)	-118.1%	-226.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-948.5
EV/GP/RG	N/A	N/A
Ticker research	View ANVS research	View CRBU research